AzTrials
AzTrials

Premature NewbornEMMASENSNCT04315428

Study of Swaddling on Tactile Learning in Premature Infants

An observational study of Premature Newborn, run by University Hospital, Grenoble at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Explore the sensorially of the premature newborn that is fundamental to adapting the care environment to these hospitalized babies Read more about this study

Who is it for?
Any age
Conditions the study is for
Premature Newborn
What is being tested?
swaddling and no swaddling
How many people
40 participants
Where
1 siteFrance
Study dates
12 Dec 2018to 23 May 2019
How long will I take part?
2 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Children born prematurely and hospitalized in the neonatal and neonatal resuscitation unit at the University Hospital of Grenoble

Who may be able to join

  • Children born prematurely and aged 28 to 35 Weeks of Amenorrhoea, regardless of their postnatal age

Who cannot join

  • premature newborns with
  • associated anomalies syndrome
  • abnormal cranial ultrasonography with stage III or IV intraventricular hemorrhage or periventricular cavitary leukaemia
  • those receiving sedative or convulsive treatment during the experiment
  • those whose grasping reflex is absent

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu Grenoble Alpes

    Grenoble, 38000

Other trials in France

About this study

Explore the sensorially of the premature newborn that is fundamental to adapting the care environment to these hospitalized babies

Read the detailed description

Indeed, the challenge is to offer them an environment adapted to their sensory skills, so as not to alter their development.

This is in line with the customized care development, better known as the Anglo-Saxon term of Neonatal Individualised Developmental Care and Assessment Program.

The aim is thus to promote later the cognitive development of these children

Being tested
swaddling, no swaddling
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • swaddlingBehavioural

    The two experimenters together evaluate the child's state of awakening throughout the experiment. If the child is considered by both experimenters to be too restless or too sleepy, the experiment is immediately stopped and postponed

  • no swaddlingBehavioural

    The two experimenters together evaluate the child's state of awakening throughout the experiment. If the child is considered by both experimenters to be too restless or too sleepy, the experiment is immediately stopped and postponed

Study groups in NCT04315428
Study groupRoleWhat they receive
premature swaddledthe childs in this group will be wrap in a lange (swaddled)
Receives: Behavioral: swaddling
premature no swaddledthe childs in this group will be not swaddled
Receives: Behavioral: no swaddling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. time required to habituate a first object (corresponding to a time when the object is held repeatedly) and time required to present a new object (corresponding to the property of discrimination)

    time required to habituate a first object (corresponding to a time when the object is held repeatedly) and time required to present a new object (corresponding to the property of discrimination)

    Measured: up to 3 months max

Secondary outcomes (1)
  1. Compare cognitive development at 2 years in both groups

    Global development quotient, derived from the Brunet-Lezine scale, (performed systematically as part of the normal follow-up of premature babies in the N\&D care network).

    the Brunet-Lezine scale : it is a global development quotient (QD) which is calculated and which corresponds to a standardized score (average of 100). Higher score corresponds to better child development

    Measured: between first evaluation and 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2020
  2. Study start12 Dec 2018
  3. Primary completion23 May 2019
  4. Study completion23 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
40 participants (actual)
Target duration
2 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT04315428
Sponsor's protocol ID
38RC18.060
Acronym
EMMASENS
Status last verified
Mar 2020
First submitted
19 Dec 2019
Last updated
19 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Lejeune F, Delacroix E, Gentaz E, Berne-Audeoud F, Marcus L, Debillon T. Influence of swaddling on tactile manual learning in preterm infants. Early Hum Dev. 2021 Feb;153:105288. doi: 10.1016/j.earlhumdev.2020.105288. Epub 2020 Dec 3.

    PubMed 33291020

Questions about this trial

What is this clinical trial studying?

An observational study of Premature Newborn, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

time required to habituate a first object (corresponding to a time when the object is held repeatedly) and time required to present a new object (corresponding to the property of discrimination) (time frame: up to 3 months max). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04315428, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in